• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗不同步继发患者出现心力衰竭加重和心房颤动:一例报告

Worsening Heart Failure and Atrial Flutter in a Patient Secondary to Cardiac Resynchronization Therapy Dyssynchrony: A Case Report.

作者信息

Khan Zahid, Besis George, Tomson Joseph

机构信息

Acute Medicine, Mid and South Essex NHS Foundation Trust, Southend-on-Sea, GBR.

Cardiology and General Medicine, Barking, Havering and Redbridge University Hospitals NHS Trust, London, GBR.

出版信息

Cureus. 2022 Sep 12;14(9):e29096. doi: 10.7759/cureus.29096. eCollection 2022 Sep.

DOI:10.7759/cureus.29096
PMID:36258951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9572945/
Abstract

Cardiac resynchronization therapy-defibrillator (CRT-D) and/or cardiac resynchronization therapy-pacemaker (CRT-P) play an important role in improving cardiac synchronization and reducing the risk of ventricular fibrillation arrest (VFA) in patients with severe left ventricular systolic dysfunction (LVSD). Patients with LVSD may notice worsening symptoms when CRT-D or CRT-P is in dyssynchrony. We present a case of 59-year-old patient who presented with worsening shortness of breath (SOB) and progressive exertional dyspnea for the past few weeks accompanied by pink, frothy sputum, occasional urinary incontinence and urge. He was known to have severe LVSD with an ejection fraction of 10% and had CRT-D in situ. Clinical examination revealed bilateral crepitation and normal heart sounds. A chest radiograph showed pulmonary oedema. An electrocardiogram (ECG) showed atrial fibrillation (AF)/flutter with wide QRS complexes. The patient was treated for acute pulmonary oedema and had CRT-D reprogrammed to achieve biventricular synchrony. He was treated with intravenous furosemide and alternate day metolazone initially. He showed significant subjective and objective improvement and was planned for outpatient synchronized intra-device cardioversion. This case is important because patients with severe LVSD with malfunctioning cardiac resynchronization therapy can result in worsening heart failure (HF) leading to higher morbidity and mortality.

摘要

心脏再同步化治疗除颤器(CRT-D)和/或心脏再同步化治疗起搏器(CRT-P)在改善心脏同步性以及降低严重左心室收缩功能障碍(LVSD)患者发生心室颤动骤停(VFA)风险方面发挥着重要作用。当CRT-D或CRT-P不同步时,LVSD患者可能会注意到症状恶化。我们报告一例59岁患者,在过去几周出现气短(SOB)加重和进行性劳力性呼吸困难,伴有粉红色泡沫痰、偶尔的尿失禁和尿急。已知他患有严重LVSD,射血分数为10%,体内植入了CRT-D。临床检查发现双侧捻发音,心音正常。胸部X线片显示肺水肿。心电图(ECG)显示房颤(AF)/房扑伴宽QRS波群。该患者接受了急性肺水肿治疗,并对CRT-D进行重新编程以实现双心室同步。最初给予静脉注射呋塞米和隔日服用美托拉宗治疗。他在主观和客观上都有显著改善,并计划进行门诊设备内同步心脏复律。这个病例很重要,因为严重LVSD且心脏再同步化治疗功能异常的患者可能会导致心力衰竭(HF)恶化,从而导致更高的发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/150071b97183/cureus-0014-00000029096-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/fa7c9e8f6e23/cureus-0014-00000029096-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/354eb9095181/cureus-0014-00000029096-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/6474afc79286/cureus-0014-00000029096-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/e2379b2f902a/cureus-0014-00000029096-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/25bb8ec5998f/cureus-0014-00000029096-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/f59b1f810ffc/cureus-0014-00000029096-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/150071b97183/cureus-0014-00000029096-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/fa7c9e8f6e23/cureus-0014-00000029096-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/354eb9095181/cureus-0014-00000029096-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/6474afc79286/cureus-0014-00000029096-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/e2379b2f902a/cureus-0014-00000029096-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/25bb8ec5998f/cureus-0014-00000029096-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/f59b1f810ffc/cureus-0014-00000029096-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb38/9572945/150071b97183/cureus-0014-00000029096-i07.jpg

相似文献

1
Worsening Heart Failure and Atrial Flutter in a Patient Secondary to Cardiac Resynchronization Therapy Dyssynchrony: A Case Report.心脏再同步治疗不同步继发患者出现心力衰竭加重和心房颤动:一例报告
Cureus. 2022 Sep 12;14(9):e29096. doi: 10.7759/cureus.29096. eCollection 2022 Sep.
2
Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard CRT-D device.使用标准心脏再同步治疗除颤器(CRT-D)对一名左心室收缩功能障碍合并心房颤动患者进行双部位右心室和左心室起搏。
J Saudi Heart Assoc. 2013 Jul;25(3):213-8. doi: 10.1016/j.jsha.2013.01.003. Epub 2013 Jan 26.
3
The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).心脏再同步治疗除颤器与植入式心脏复律除颤器患者中,间歇性房性快速心律失常对心力衰竭或死亡的影响:MADIT-CRT 亚研究(多中心自动除颤器植入试验与心脏再同步治疗)。
J Am Coll Cardiol. 2014 Apr 1;63(12):1190-1197. doi: 10.1016/j.jacc.2013.10.074. Epub 2013 Dec 11.
4
Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.心脏再同步除颤器治疗阵发性心房颤动患者的多中心RENEWAL 3 AVT临床研究结果。
J Cardiovasc Electrophysiol. 2006 May;17(5):520-5. doi: 10.1111/j.1540-8167.2006.00440.x.
5
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
6
Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.COMPANION试验中伴有间歇性心房颤动或心房扑动患者的心脏再同步治疗结果
Heart Rhythm. 2017 Jun;14(6):858-865. doi: 10.1016/j.hrthm.2017.03.024. Epub 2017 Mar 18.
7
Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.右心室导线位置对 CRT-D 患者临床结局和室性心律失常发生率的影响。
Heart Rhythm. 2013 Dec;10(12):1770-7. doi: 10.1016/j.hrthm.2013.08.020. Epub 2013 Aug 22.
8
Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation.收缩功能障碍患者行房颤消融时舒张功能障碍的预后意义
Int J Cardiol Heart Vasc. 2022 Jul 4;41:101079. doi: 10.1016/j.ijcha.2022.101079. eCollection 2022 Aug.
9
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.轻度症状性心力衰竭患者以及无症状左心室功能不全且既往有心力衰竭症状患者心脏再同步化治疗的随机试验。
J Am Coll Cardiol. 2008 Dec 2;52(23):1834-1843. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.
10
Cardiac resynchronization therapy improves left atrial reservoir function through resynchronization of the left atrium in patients with heart failure with reduced ejection fraction.心脏再同步治疗通过使心力衰竭伴射血分数降低患者的左心房再同步化来改善左心房储器功能。
Int J Cardiovasc Imaging. 2020 Jul;36(7):1203-1212. doi: 10.1007/s10554-020-01813-9. Epub 2020 Mar 18.

本文引用的文献

1
2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronisation Therapy.2021年欧洲心脏病学会心脏起搏与心脏再同步治疗指南。
Eur Cardiol. 2021 Dec 14;16:e55. doi: 10.15420/ecr.2021.51. eCollection 2021 Feb.
2
Mechanical dyssynchrony after cardiac resynchronization therapy for severely symptomatic heart failure is associated with risk for ventricular arrhythmias.严重症状性心力衰竭患者接受心脏再同步治疗后的机械不同步与室性心律失常风险相关。
J Am Soc Echocardiogr. 2014 Aug;27(8):872-9. doi: 10.1016/j.echo.2014.04.001. Epub 2014 May 3.
3
Electromechanical dyssynchrony and resynchronization of the failing heart.
心脏衰竭中的机电失同步和再同步。
Circ Res. 2013 Aug 30;113(6):765-76. doi: 10.1161/CIRCRESAHA.113.300270.
4
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.心脏再同步化治疗改善左心室不同步与收缩功能的关系及其临床转归:MADIT-CRT 试验。
Eur Heart J. 2011 Jul;32(14):1720-9. doi: 10.1093/eurheartj/ehr185. Epub 2011 May 24.
5
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).多中心自动除颤器植入试验-心脏再同步治疗(MADIT-CRT)中 QRS 形态对心脏再同步治疗效果的影响。
Circulation. 2011 Mar 15;123(10):1061-72. doi: 10.1161/CIRCULATIONAHA.110.960898. Epub 2011 Feb 28.
6
Age, increased left ventricular mass, and lower regional myocardial perfusion are related to greater extent of myocardial dyssynchrony in asymptomatic individuals: the multi-ethnic study of atherosclerosis.年龄、左心室质量增加以及局部心肌灌注降低与无症状个体心肌不同步程度加剧相关:动脉粥样硬化多民族研究。
Circulation. 2009 Sep 8;120(10):859-66. doi: 10.1161/CIRCULATIONAHA.108.787408. Epub 2009 Aug 24.
7
Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy.心脏再同步治疗增强β-肾上腺素能储备的机制。
Circulation. 2009 Mar 10;119(9):1231-40. doi: 10.1161/CIRCULATIONAHA.108.774752. Epub 2009 Feb 23.
8
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.美国心脏病学会/美国心脏协会成人慢性心力衰竭诊断和治疗指南2005年更新版:美国心脏病学会/美国心脏协会实践指南工作组(更新2001年心力衰竭评估和管理指南写作委员会)报告:与美国胸科医师学会及国际心肺移植学会合作制定:得到心律学会认可。
Circulation. 2005 Sep 20;112(12):e154-235. doi: 10.1161/CIRCULATIONAHA.105.167586. Epub 2005 Sep 13.
9
Heart failure.心力衰竭
Lancet. 2005;365(9474):1877-89. doi: 10.1016/S0140-6736(05)66621-4.
10
The effect of cardiac resynchronization on morbidity and mortality in heart failure.心脏再同步化治疗对心力衰竭患者发病率和死亡率的影响。
N Engl J Med. 2005 Apr 14;352(15):1539-49. doi: 10.1056/NEJMoa050496. Epub 2005 Mar 7.